<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN"
       "https://jats.nlm.nih.gov/publishing/1.3/JATS-journalpublishing1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" dtd-version="1.3" article-type="research-article" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="nlm-ta">Ulutas Med J</journal-id>
   <journal-title-group>
    <journal-title>The Ulutas Medical Journal</journal-title>
    <abbrev-journal-title>Ulutas Med J</abbrev-journal-title>
   </journal-title-group>
   <issn pub-type="ppub">2149-0430</issn>
   <issn pub-type="epub">2149-388X</issn>
   <publisher>
    <publisher-name>Hayriye Zehra Ulutaş</publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">10.5455/umj.20210520114119</article-id>
   <article-id pub-id-type="publisher-id">82600</article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>Original Article</subject>
    </subj-group>
    <subj-group subj-group-type="subject">
     <subject>Gynaecology and Obstetrics</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title>The Relationship of Non-dipper Blood Pressure Pattern with the Fragmented QRS Morphology on ECG and the Role of Inflammatory Biomarkers in Polycystic Ovary Syndrome</article-title>
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" corresp="yes">
     <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8519-1883</contrib-id>
     <name name-style="western">
      <surname>Erkayiran</surname>
      <given-names>Ugurkan</given-names>
     </name>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
     <xref ref-type="aff" rid="aff1">1</xref>
    </contrib>
    <contrib contrib-type="author">
     <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1939-1008</contrib-id>
     <name name-style="western">
      <surname>Aksu</surname>
      <given-names>Ekrem</given-names>
     </name>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
     <xref ref-type="aff" rid="aff1">1</xref>
    </contrib>
    <contrib contrib-type="author">
     <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9686-1603</contrib-id>
     <name name-style="western">
      <surname>Arslanca</surname>
      <given-names>Tufan</given-names>
     </name>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
     <xref ref-type="aff" rid="aff2">2</xref>
    </contrib>
    <aff id="aff1">
     <label>1</label>
     <institution-wrap>
      <institution-id institution-id-type="ror">https://ror.org/03gn5cg19</institution-id>
      <institution>Kahramanamaras Sutcu Imam University</institution>
     </institution-wrap>
    </aff>
    <aff id="aff2">
     <label>2</label>
     <institution-wrap>
      <institution-id institution-id-type="ror">https://ror.org/04dj8ng22</institution-id>
      <institution>Ankara Ufuk University</institution>
     </institution-wrap>
    </aff>
   </contrib-group>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2021-09-26">
    <day>26</day>
    <month>09</month>
    <year>2021</year>
   </pub-date>
   <pub-date publication-format="print" date-type="collection">
    <year>2021</year>
   </pub-date>
   <volume>7</volume>
   <issue>3</issue>
   <fpage>157</fpage>
   <lpage>164</lpage>
   <history>
    <date date-type="received" iso-8601-date="2021-05-20">
     <day>20</day>
     <month>05</month>
     <year>2021</year>
    </date>
    <date date-type="rev-recd" iso-8601-date="2021-06-27">
     <day>27</day>
     <month>06</month>
     <year>2021</year>
    </date>
    <date date-type="accepted" iso-8601-date="2021-07-21">
     <day>21</day>
     <month>07</month>
     <year>2021</year>
    </date>
   </history>
   <permissions>
    <copyright-statement>© 2021 The Author(s)</copyright-statement>
    <copyright-year>2021</copyright-year>
    <license>
     <ali:license_ref>https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
     <license-p>This is an open access article distributed under the CC BY-NC 4.0 licence.</license-p>
    </license>
   </permissions>
   <self-uri xlink:href="https://www.ulutasmedicaljournal.com/?mno=82600"/>
   <self-uri content-type="pdf" xlink:href="https://www.ulutasmedicaljournal.com/pdf/82600.pdf"/>
   <abstract>
    <p>Introduction: This study aimed to investigate the relationship between the fragmented QRS (fQRS) morphology and hematological markers and non-dipper blood pressure patterns in patients with polycystic ovary syndrome (PCOS). Materials and Methods: Sixty-five patients with PCOS between the ages of and 18-40 years were included in the study. Control and patients were compared in terms of laboratory findings, electrocardiograms, and holter results. Results: In the PCOS, non-dipper patterns in systolic and diastolic blood pressure were more common, but only the non-dipper pattern showed significance in systolic blood pressure (p=0.007). In both groups, the non-dipper blood pressure was more frequent in those with fragmented QRS. Neutrophil (p=0.01), lymphocyte (p=0.002), neutrophil-lymphocyte ratio(p&lt;0.0001), monocyte-lymphocyte ratio(p=0.014), platelet lymphocyte ratios (p=0.001), erythrocyte distribution width (p&lt;0.0001), and platelet distribution width (p=0.001) were higher in the PCOS than in the control. Conclusion: The levels of inflammatory markers and the frequency of non-dipper blood pressure patterns are increased in PCOS. In these patients, the fQRS morphology may be used to distinguish those with non-dipping blood pressure patterns.</p>
   </abstract>
   <kwd-group kwd-group-type="author">
    <kwd>Cardiovascular disease</kwd>
    <kwd>insulin resistance</kwd>
    <kwd>inflammation</kwd>
    <kwd>polycystic ovary syndrome</kwd>
    <kwd>non-dipper blood pressure pattern</kwd>
    <kwd>fragmented QRS</kwd>
   </kwd-group>
   <funding-group>
    <funding-statement>The author(s) received no financial support for the research, authorship, and/or publication of this article.</funding-statement>
   </funding-group>
  </article-meta>
 </front>
 <body>
  <sec id="sec-1">
   <title>Introduction</title>
   <p id="b-1">Polycystic ovary syndrome (PCOS) is a syndrome characterized by amenorrhea, oligomenorrhea, irregular bleeding, hirsutism, and/or obesity in 5%–10% of women in their reproductive period (    <xref ref-type="bibr" rid="ref1">1</xref>
). The risk of cardiovascular disease increases in addition to Type-2 DM, endometrial cancer, and spontaneous abortion in PCOS patients (    <xref ref-type="bibr" rid="ref2">2</xref>
). The risk of death and myocardial infarction increased 3.3fold in these individuals, followed by cardiovascular reasons (    <xref ref-type="bibr" rid="ref3">3</xref>
).</p>
   <p id="b-2">Many studies have been conducted in recent years on the relationship between PCOS and an enhanced risk of cardiovascular disease. A contributing factor to the elevated cardio vascular risk status in these patients may be the high frequency of non-dipper blood pressure patterns. The non-dipping blood pressure pattern was a prominent prognostic indicator for cardiovascular morbidity and mortality in hypertensive and non-hypertensive individuals (    <xref ref-type="bibr" rid="ref4">4</xref>
,    <xref ref-type="bibr" rid="ref5">5</xref>
). Increased inflammation in these patients may also be another mechanism to explain the increased cardiovascular risk.</p>
   <p id="b-3">It has been reported that fragmented QRS (fQRS) morphology can be used to predict non-dipper blood pressure patterns on electrocardiography (ECG). To the best of our knowledge, no study has investigated the connection between the non-dipper blood pressure pattern and fQRS in patients with PCOS. In this study, we aimed to examine the relationship between fQRS morphology and hematological inflammation markers, which are potential threat indicators of cardiovascular diseases in patients with PCOS, and the non-dipper blood pressure pattern.</p>
  </sec>
  <sec id="sec-2">
   <title>Materials and Methods</title>
  </sec>
  <sec id="sec-3">
   <title>Study Design</title>
   <p id="b-4">The present study analyzed the relationship between fQRS morphology and hematological inflammation markers, which are potential threat indicators of cardiovascular diseases in patients with PCOS, and the non-dipper blood pressure pattern. Ninety patients who applied to the Obstetrics and Gynecology outpatient clinic were included in the present study. The patients were divided into two groups as PCOS and controls.</p>
  </sec>
  <sec id="sec-4">
   <title>Ethical Statement</title>
   <p id="b-5">The study was administered after consent was obtained from the ethics committee. Approval from the local ethics committee was obtained (date: 24/06/2020, Session: 2020/12, Decision Number:09). Following the Helsinki Declaration, voluntary consent forms of patients included in the study were obtained (06/03/2017-No:02).</p>
   <sec id="sec-5">
    <title>Inclusion/Exclusion Criteria</title>
    <p id="b-6">Patients with two positive findings of hirsutism, polycystic ovarian appearance, and menstrual irregularity were included in the PCOS (n:65), and patients without two positive findings were included in the control group (n:35). ECG without sinusoidal rhythm, left ventricular systolic dysfunction, heart valve disease, left ventricular hypertrophy, atrial fibrillation, morbid obesity (BMI&gt;40 kg/m     <sup>2</sup>
), smoking and alcohol use, history of systemic disease (hypertension, diabetes mellitus, renal failure, connective tissue disease, thyroid dysfunction, etc.), patients with fluid-electrolyte imbalance were excluded from the study. Demographic and laboratory data of all patients included in the study were recorded.</p>
   </sec>
   <sec id="sec-6">
    <title>Cardiological Assessment</title>
    <p id="b-7">In the study and control groups, 12-lead ECGs were derived at 10 mm/mV amplitude and 25 mm/s. The fQRS component was evaluated for all ECG leads. Fragmented QRS was defined as notching in two adjacent R or S waves, where QRS lasted &lt;120 ms without any bundle branch block in the areas of blood supply to the major coronary artery (     <xref ref-type="bibr" rid="ref6">6</xref>
). 24-h Holter blood pressure was measured to investigate the diurnal rhythm of the patients' daily blood pressure. For the Holter recording to be considered valid, the conditions of using it for at least 24 hours, measuring blood pressure every 15 minutes during the day, every 30 minutes at night, and an erroneous measurement rate of less than 20% was stipulated.From Holter blood pressure records, daytime, nighttime, and 24-h systolic blood pressure and diastolic blood pressure, as well as the mean daytime-nighttime systolic and diastolic blood pressure differences, were calculated. Individuals with a blood pressure decrease of more than 10% at night were accepted as dipper and those with less than 10% of the non-dipper blood pressure pattern (     <xref ref-type="bibr" rid="ref7">7</xref>
). 12-lead surface ECG recordings at rest were stored to evaluate the presence of fQRS morphology and its association with the non-dipper blood pressure pattern. Patients in both groups were asked to visit on the second or third day of the study period.</p>
   </sec>
   <sec id="sec-7">
    <title>Demographics and Lanoratory Analysis</title>
    <p id="b-8">Patient age, height, weight, body mass index (BMI), fasting glucose (FBG), total cholesterol, triglyceride, LDL, HDL, BUN, creatinine, AST, ALT, FSH, LH, sodium, potassium, prolactin, estradiol, TSH, and hemogram were ordered. The sub-parameters of neutrophil, lymphocyte, monocyte, platelet, erythrocyte distribution width (RDW-SD), platelet distribution width (PDW), and red blood cells (RBC) in the hemogram were evaluated. Neutrophil lymphocyte ratio (NLR), monocyte lymphocyte ratio (MLR), and platelet lymphocyte ratio (PLR) were calculated. The relationship between hematological markers, 24-hour ambulatory blood pressure results, non-dipper blood pressure pattern, and the presence of fQRS morphology on ECG were investigated.</p>
   </sec>
   <sec id="sec-8">
    <title>Statistical Data</title>
    <p id="b-9">All analysis were given with details in the tables. The frequency and percentage of categorical data and median (clearance) for continuous data are presented as descriptive values. For comparisons between groups, the &quot;Mann- Whitney U-test was used for the two groups, while the &quot; chi-square test was used to compare categorical variables. Results were considered statistically significant when the p-value was less than 0.05 (p&lt;0.05). The collected patient data were analyzed using IBM Statistical Package for the Social Sciences (SPSS) for Windows 23.0.</p>
   </sec>
  </sec>
  <sec id="sec-9">
   <title>Results</title>
   <p id="b-10">In demographic assessmnets, there were no differences in age and height between the two groups. A significant difference was found in weight and BMI in the PCOS (p&lt;0.0001 and p&lt;0.0001,respectively). No significant difference was observed between the two groups for 24- hour mean systolic, diastolic, mean daytime systolic, diastolic, and mean nighttime systolic and diastolic blood pressures. A significant difference was found in the PCOS group in terms of the mean daytime/nighttime systolic blood pressure difference. However, when both groups were compared in terms of daytime/nighttime diastolic blood pressure difference, although the change in the PCOS group was less, it was not considered significant.</p>
   <p id="b-11">Although significant differences were observed in FBG and HDL in both groups, no difference was found in terms of total cholesterol, triglyceride, LDL, BUN, creatinine, potassium, sodium, AST, and ALT values. In terms of LH/FSH, this ratio was observed to be increased in the PCOS group and was found to be significant. There were no differences in PRL, estradiol, TSH, and hemoglobin values.</p>
   <p id="b-12">In terms of hemogram, monocyte and platelet counts were not significantly different in both groups, while neutrophil and lymphocyte counts showed an increase in favor of PCOS, and this difference was considered significant. In terms of NLR, MLR, PLR, RDW-SD, and PDW values, these values were found to be increased in the PCOS group, and this was considered significant. No difference was found in either group in terms of RBC values (Tables 1 and 2). When patients with ECG fragmentation were evaluated in terms of the daytime/nighttime mean systolic blood pressure difference, although the difference in the PCOS group was less, this was not significant (p=0.765). When both groups without ECG fragmentation were compared, no significant difference was found in terms of daytime/nighttime systolic pressure difference (p=0,289). ECG fragmentation had a non-dipper pressure pattern, and patients without fragmentation had a dipper blood pressure pattern in both groups. In addition, the change in the daytime/nighttime systolic blood pressure difference between both groups with ECG fragmentation was greater than the change between both groups without ECG fragmentation. When we evaluated the patients with and without ECG fragmentation in terms of daytime/nighttime systolic blood pressure difference in the control group and the PCOS group, it was observed that the change in the daytime/nighttime systolic blood pressure difference was less in patients with ECG fragmentation. When patients with and without ECG fragmentation were compared, in both groups, a difference was seen (p&lt;0.0001 and p&lt;0.0001, respectively) (Table 3).</p>
   <table-wrap id="tbl-1" position="float">
    <label>Table 1</label>
    <caption>
     <title>Distribution of Demographic and 24-hour Holter Blood Pressure Findings by Groups</title>
    </caption>
    <graphic xlink:href="tbl-1.png">
     <alt-text>Table 1: Distribution of Demographic and 24-hour Holter Blood Pressure Findings by Groups</alt-text>
    </graphic>
   </table-wrap>
   <table-wrap id="tbl-2" position="float">
    <label>Table 2</label>
    <caption>
     <title>Distribution of Hematological Findings According to Groups</title>
    </caption>
    <graphic xlink:href="tbl-2.png">
     <alt-text>Table 2: Distribution of Hematological Findings According to Groups</alt-text>
    </graphic>
   </table-wrap>
   <p id="b-13">When patients with ECG fragmentation were evaluated in terms of the daytime/nighttime mean diastolic blood pressure difference, although the difference in the control was less, this was not significant (p=0.222). When both groups without ECG fragmentation were compared, although the difference in daytime /nighttime systolic blood pressure was lower in the PCOS, the difference was not significant (p=0.888). Patients with ECG fragmentation had a non-dipper blood pressure pattern, and patients without fragmentation had a dipper blood pressure pattern in both groups. When the difference in daytime/nighttime diastolic blood pressure was compared between those with and without ECG fragmentation, a significant difference was found in both groups (p&lt;0.0001 and p&lt;0.0001, respectively) (Table 4).</p>
  </sec>
  <sec id="sec-10">
   <title>Discussion</title>
   <p id="b-14">In clinical studies of ambulatory blood pressure, a circadian rhythm was observed, and it has been shown that blood pressure drops at night and is higher during the daytime. This condition, which is part of the normal circadian rhythm, is defined as the nocturnal dipper pattern. The absence of observation of this physiological process is called the non-dipper blood pressure pattern, a condition closely connected to the dangers of a cardiovascular event and end-organ damage (    <xref ref-type="bibr" rid="ref8">8</xref>
). It has been reported that nocturnal sympathetic nervous system discharge plays a role in the formation of this pattern (    <xref ref-type="bibr" rid="ref9">9</xref>
). Deterioration of autonomic nervous system functions, which is the main cause of non-dipper blood pressure patterns, may cause adverse events by increasing peripheral vascular resistance. It has been reported that this condition emerges more frequently in obese or overweight people than in the healthy population (    <xref ref-type="bibr" rid="ref10">10</xref>
). The prevalence of cardiovascular diseases in those with non-dipper patterns is twice as high as that in healthy people of similar age (    <xref ref-type="bibr" rid="ref11">11</xref>
). It is also a condition associated with a worse prognosis of the non-dipper blood pressure pattern than the dipper blood pressure pattern (    <xref ref-type="bibr" rid="ref12">12</xref>
).</p>
   <table-wrap id="tbl-3" position="float">
    <label>Table 3</label>
    <caption>
     <title>Evaluation of Day/Night Average Systolic Blood Pressure Difference (%) Levels for Groups with QRS</title>
    </caption>
    <graphic xlink:href="tbl-3.png">
     <alt-text>Table 3: Evaluation of Day/Night Average Systolic Blood Pressure Difference (%) Levels for Groups with QRS</alt-text>
    </graphic>
   </table-wrap>
   <table-wrap id="tbl-4" position="float">
    <label>Table 4</label>
    <caption>
     <title>Evaluation of Day/Night Average Diastolic Blood Pressure Difference (%) Levels for Groups with QRS</title>
    </caption>
    <graphic xlink:href="tbl-4.png">
     <alt-text>Table 4: Evaluation of Day/Night Average Diastolic Blood Pressure Difference (%) Levels for Groups with QRS</alt-text>
    </graphic>
   </table-wrap>
   <p id="b-15">In PCOS, the three key inflammatory markers are highly and significantly correlated with BMI, according to last reports. In addition, there were correlations with other cardiovascular risk markers, including HDL, triglycerides, diastolic pressure, as well as with insulin resistance, quantified by HOMA-IR. In the previous reports, untreated PCOS demonstrated significantly increased serum concentrations of hsCRP, IL-6, and increased numbers of leukocytes, granulocytes, and lymphocytes compared to a sample of healthy women which were, however, not matched by BMI. In a study, Kargılı et al. reported that the non-dipping blood pressure pattern was higher in PCOS patients than in the control group. In addition, it has been emphasized that the non-dipper pattern may be the sole reason for creating a basis for cardiovascular diseases (    <xref ref-type="bibr" rid="ref13">13</xref>
). In line with the literature, we observed the non-dipper pattern in the PCOS group, mainly in terms of the mean daytime/nighttime systolic and diastolic blood pressure differences between the groups in our study. However, we found that the frequency of increased non-dipper pattern in patients with PCOS was statistically significant, with only a difference in systolic blood pressure. It was considered that this situation might be due to the small study volume.</p>
   <p id="b-16">Distinguishing those with non-dipper blood pressure patterns in patients with PCOS may be important in reducing cardiovascular risk. Therefore, these patients need to have markers that indicate a non-dipper blood pressure pattern. In a recent study, Eyüboğlu &amp; Akdeniz showed that fQRS may be predictive of non-dipper pressure patterns in prehypertensive patients. (    <xref ref-type="bibr" rid="ref14">14</xref>
). fQRS is a finding that occurs during many cardiovascular diseases. It has been shown that fQRS is also associated with increased blood pressure in patients with a non-dipper cardiac pattern, and a narrow fQRS complex seen on ECG indicates delayed ventricular conduction disturbance as well as myocardial damage and fibrosis (    <xref ref-type="bibr" rid="ref15">15</xref>
,    <xref ref-type="bibr" rid="ref16">16</xref>
). Therefore, determining the predictive role of the non-dipper blood pressure pattern of fQRS in PCOS patients may be important for the early detection of patients with high cardiovascular risk. In this study, we found that fQRS data correlated with non-dipper blood pressure in both groups. We also found that the non-dipper blood pressure pattern was more frequent in the PCOS group than in the control group. These results show that fQRS can be used in ECG to predict non-dipper blood pressure in patients with PCOS.</p>
   <p id="b-17">In studies in the literature, many different inflammatory markers have been observed to increase in patients with PCOS. Due to its relationship with obesity, insulin resistance has been identified in patients with PCOS, and increased levels of free fatty acids, TNF-α, and CRP have been detected (    <xref ref-type="bibr" rid="ref10">10</xref>
). In a study, Patel et al. observed increases in all inflammatory markers and intima-media thickness in PCOS patients (    <xref ref-type="bibr" rid="ref17">17</xref>
). Samy et al. demonstrated that inflammatory markers were investigated in 108 PCOS patients and 75 healthy volunteers, and it has been shown that CRP, IL-6, and TNF-α significantly increased and correlated with BMI and HOMA-IR when measured against the control group (    <xref ref-type="bibr" rid="ref18">18</xref>
). In this study, while statistically significantly high FBG and low HDL were observed in both PCOS groups, no statistically significant difference was found for total cholesterol, triglyceride, LDL, BUN, creatinine, sodium, potassium, AST, and ALT levels. In terms of LH/FSH, this ratio was observed to be increased in the PCOS group and was found to be statistically significant. There were no statistical differences in PRL, estradiol, TSH, and hemoglobin values. In terms of hemogram sub-parameters, neutrophil and lymphocyte counts showed an increase in favor of PCOS, and this difference was considered statistically significant. Neutrophil, lymphocyte, NLR, MLR, PLR, RDW, and PDW values, which are hematological inflammation markers, were found to be significantly higher in the PCOS group. These high levels of hematological inflammation markers may explain the rise in cardiovascular threats in patients with PCOS (    <xref ref-type="bibr" rid="ref19">19</xref>
). In our study, we showed that the fQRS pattern is closely associated with the non-dipping blood pressure pattern. We uniquely demonstrated in the literature that the fQRS pattern may play a predictive role in distinguishing those with non-dipping blood pressure patterns in PCOS patients. In addition, consistent with the literature, the presence of increased inflammation in PCOS patients was shown through the hematological inflammation markers used in the study.</p>
   <p id="b-18">As a result, the dominance of the non-dipper blood pressure pattern may be a mechanism contributing to the high cardiovascular risk in this group. Fragmented QRS morphology on ECG may be a parameter in the differentiation of PCOS patients with increased cardiovascular risk due to non-dipper blood pressure.</p>
  </sec>
 </body>
 <back>
  <ref-list>
   <title>References</title>
   <ref id="ref1">
    <label>1</label>
    <mixed-citation publication-type="journal">Sherwood A, Bower JK, Routledge FS, Blumenthal JA, McFetridge-Durdle JA, Newby LK, et al. Nighttime blood pressure dipping in postmenopausal women with coronary heart disease. Am J Hypertens. 2012 Oct;25(10):1077-82</mixed-citation>
   </ref>
   <ref id="ref2">
    <label>2</label>
    <mixed-citation publication-type="journal">Cai A, Zhong Q, Liu C, Zhou D, Li X, Zhang Y, et al. Associations of systolic and diastolic blood pressure night-to-day ratios with atherosclerotic cardiovascular diseases. Hypertens Res. 2016 Dec;39(12):874-8</mixed-citation>
   </ref>
   <ref id="ref3">
    <label>3</label>
    <mixed-citation publication-type="journal">Routledge FS, Hinderliter AL, McFetridge-Durdle J, Blumenthal JA, Paine NJ, Sherwood A. Endothelial function in postmenopausal women with nighttime systolic hypertension. Menopause. 2015 Aug;22(8):857-63</mixed-citation>
   </ref>
   <ref id="ref4">
    <label>4</label>
    <mixed-citation publication-type="journal">Hansen TW, Li Y, Boggia J, Thijs L, Richart T, Staessen JA. Predictive role of the nighttime blood pressure. Hypertension. 2011;57(1):3-10</mixed-citation>
   </ref>
   <ref id="ref5">
    <label>5</label>
    <mixed-citation publication-type="journal">de la Sierra A, Gorostidi M, Banegas JR, Segura J, de la Cruz JJ, Ruilope LM. Nocturnal hypertension or nondipping: which is better associated with the cardiovascular risk profile?. Am J Hypertens. 2014;27(5):680-7</mixed-citation>
   </ref>
   <ref id="ref6">
    <label>6</label>
    <mixed-citation publication-type="journal">Stewart JM. Mechanisms of sympathetic regulation in orthostatic intolerance. J Appl Physiol (1985). 2012;113(10): 1659-68</mixed-citation>
   </ref>
   <ref id="ref7">
    <label>7</label>
    <mixed-citation publication-type="journal">Cuspidi C, Giudici V, Negri F, Sala C. Nocturnal nondipping and left ventricular hypertrophy in hypertension: an updated review. Expert Rev Cardiovasc Ther. 2010;8(6):781-92 164 77 Polycystic Ovary Syndrome Erkayiran et al.</mixed-citation>
   </ref>
   <ref id="ref8">
    <label>8</label>
    <mixed-citation publication-type="journal">Passino C, Magagna A, Conforti F, Buralli S, Kozáková M, Palombo C, et al. Ventricular repolarization is prolonged in nondipper hypertensive patients: role of left ventricular hypertrophy and autonomic dysfunction. J Hypertens. 2003 Feb;21(2):445-51</mixed-citation>
   </ref>
   <ref id="ref9">
    <label>9</label>
    <mixed-citation publication-type="journal">Salles GF, Reboldi G, Fagard RH, Cardoso CR, Pierdomenico SD, Verdecchia P, et al. ABC-H Investigators. Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients: The Ambulatory Blood Pressure Collaboration in Patients With Hypertension (ABC-H) Meta-Analysis. Hyper tension. 2016 Apr;67(4):693-700</mixed-citation>
   </ref>
   <ref id="ref10">
    <label>10</label>
    <mixed-citation publication-type="journal">Nakano S, Kitazawa M, Tsuda S, Himeno M, Makiishi H, Nakagawa A, et al. Insulin resistance is associated with reduced nocturnal falls of blood pressure in normotensive, nonobese type 2 diabetic subjects. Clin Exp Hypertens. 2002 Jan-Feb;24(1-2):65-73</mixed-citation>
   </ref>
   <ref id="ref11">
    <label>11</label>
    <mixed-citation publication-type="journal">Sherwood A, Steffen PR, Blumenthal JA, Kuhn C, Hinderliter AL. Nighttime blood pressure dipping: the role of the sympathetic nervous system. Am J Hypertens. 2002;15(21): 111-8</mixed-citation>
   </ref>
   <ref id="ref12">
    <label>12</label>
    <mixed-citation publication-type="journal">Das MK, Saha C, El Masry H, Peng J, Dandamudi G, Mahenthiran J, et al. Fragmented QRS on a 12 -lead ECG: a predictor of mortality and cardiac events in patients with coronary artery disease. Heart Rhythm. 2007;4(11):1385-92</mixed-citation>
   </ref>
   <ref id="ref13">
    <label>13</label>
    <mixed-citation publication-type="journal">Kargili A, Karakurt F, Kasapoglu B, Derbent A, Koca C, Selcoki Y. Association of polycystic ovary syndrome and a non-dipping blood pressure pattern in young women. Clinics (Sao Paulo). 2010;65(5):475-9</mixed-citation>
   </ref>
   <ref id="ref14">
    <label>14</label>
    <mixed-citation publication-type="journal">Eyuboglu M, Akdeniz B. Association Between Non-Dipping and Fragmented QRS Complexes in Prehypertensive Patients. Arq Bras Cardiol. 2019;112(1):59-64</mixed-citation>
   </ref>
   <ref id="ref15">
    <label>15</label>
    <mixed-citation publication-type="journal">Romero-Corral A, Caples SM, Lopez-Jimenez F, Somers VK. Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest. 2010;137(3):711-9</mixed-citation>
   </ref>
   <ref id="ref16">
    <label>16</label>
    <mixed-citation publication-type="journal">Jain R, Singh R, Yamini S, Das MK. Fragmented ECG as a risk marker in cardiovascular diseases. Curr Cardiol Rev. 2014;10 (3):277-86</mixed-citation>
   </ref>
   <ref id="ref17">
    <label>17</label>
    <mixed-citation publication-type="journal">Patel SS, Truong U, King M, Ferland A, Moreau KL, Dorosz J, et al. Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers. Vasc Med. 2017 Apr;22(2):85-95</mixed-citation>
   </ref>
   <ref id="ref18">
    <label>18</label>
    <mixed-citation publication-type="journal">Samy N, Hashim M, Sayed M, Said M. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index. Dis Markers. 2009;26(4):163-70</mixed-citation>
   </ref>
   <ref id="ref19">
    <label>19</label>
    <mixed-citation publication-type="journal">Polónia J, Amaral C, Bertoquini S, Martins L. Attenuation of heart rate recovery after exercise in hypertensive patients with blunting of the nighttime blood pressure fall. Int J Cardiol. 2006;106(2):238-43</mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>
